FDA Expands Use of Approved Breast Cancer Drug
Provides oral regime for hormone positive and HER2-positive advanced breast cancerThe U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in…






